Wall Street expects a year-over-year increase in earnings on higher revenues when ResMed (RMD) reports results for the quarter ended March 2025. While this widely-known consensus outlook is ...

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea. The NightOwl testing device, about the size of a quarter, is worn on the ...

ResMed launched NightOwl™, a home sleep apnea test that enhances user convenience with a small fingertip sensor and cloud data evaluation. Despite the broader market reacting negatively to new ...

Shares of ResMed Inc. RMD shed 1.16% to $211.49 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and ...

Learn More I've been keeping a close eye on the ResMed Inc (ASX: RMD) share price for a while now. There's a lot to like about ResMed. I'm particularly keen on the fact that the company has a ...

Shares of ResMed Inc. RMD slipped 2.72% to $210.55 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 3.46% to 5,268.05 and ...

ResMed Inc. (RMD), headquartered in San Diego, California, specializes in designing and delivering medical devices and cloud-connected software for the healthcare sector. With a market cap of $33 ...

ResMed Trading Up 0.3 % Shares of RMD stock opened at $222.62 on Friday. The company has a 50-day moving average of $234.10 and a two-hundred day moving average of $238.43. The firm has a market ...

“When you travel, you only have so much space — size really matters when it comes to the product,” said Charles Hartson, product leader at Resmed, a manufacturer of CPAPs and other medical ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1132 ET – Novo Nordisk’s American depositary receipts ...

Jean-Louis Pépin, MD “For people with OSA, using CPAP versus not using CPAP can literally be a matter of life or death,” said Carlos Nunez, MD, Resmed’s chief medical officer.